Target intelligence / Profile preview

Bombesin receptor-activated protein (BRAP)

Target
BRAP
Molecular classification
Other (Multifunctional regulatory protein), Histone deacetylase (HDAC) enhancer
01

Overview

Bombesin receptor-activated protein (BRAP) is a multifunctional protein encoded by the C6orf89 gene, serving as an enhancer of histone deacetylase activity to regulate chromatin remodeling, immune response, and cell proliferation. The protein exists as several isoforms that localize to the nucleolus, Golgi, and midbody, integrating into cellular structures associated with ribosome biogenesis, mitosis, and wound repair. BRAP modulates immune and inflammatory responses, particularly in airway epithelial cells, through HDAC-mediated suppression of NF-κB, influencing cell repair and immune surveillance. Dysregulation of BRAP is implicated in diseases including cancer, kidney injury, and congenital glycosylation disorders, where it shapes cell fate and drug response through epigenetic and transcriptional mechanisms

Other names
Bombesin receptor-activated proteinBRAPChromosome 6 open reading frame 89C6orf89AmfionPS1TP5TP1FLJ25357UNQ177/PRO203
02

Mechanism of action

Enhancement of histone deacetylase (HDAC) activity; Suppression of NF-κB transcriptional activity; Regulation of ribosomal gene transcription; Modulation via effects on SIRT2 in kidney injury

03

Biological functions

Chromatin remodelingCell cycle progressionEpithelial cell proliferationWound healingImmune and inflammatory modulation (via HDAC-enhanced suppression of NF-κB activity)
04

Disease associations

Cancer (neoantigen source, implicated in immunotherapy strategies)Acute kidney injury (cisplatin-induced)Congenital disorder of glycosylation, Type IIc
05

Safety considerations

No major direct drug safety concerns reported.Dysregulation may exacerbate cell death in acute kidney injury and alter immune response, which could impact patient safety indirectly via therapeutic modulation.
06

Biomarkers

Neoantigen peptide presence in cancer (potential for immunotherapy patient selection)Expression levels in bronchial epithelial cells for inflammation and wound healing models

Beyond the preview

Go deeper on Bombesin receptor-activated protein (BRAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bombesin receptor-activated protein (BRAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call